Is there a place for angiotensin receptor-neprilysin inhibitors in the treatment of heart failure patients after heart transplantation?

被引：1

作者：

Gulin, Dario ^{[1
,2
]}

Planinic, Zrinka ^{[1
]}

Habek, Jasna Cerkez ^{[1
,3
]}

Sikic, Jozica ^{[1
,2
]}

机构：

[1] Univ Hosp Sveti Duh, Dept Cardiovasc Dis, Sveti Duh 64, Zagreb 10000, Croatia

[2] Univ Zagreb, Sch Med, Zagreb, Croatia

[3] Croatian Catholic Univ, Zagreb, Croatia

来源：

INDIAN JOURNAL OF PHARMACOLOGY | 2019年 / 51卷 / 06期

关键词：

Heart failure; heart transplantation; sacubitril; valsartan; WORKING FORMULATION; NOMENCLATURE; DIAGNOSIS;

D O I：

10.4103/ijp.IJP_562_18

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

We present a case report of a heart failure patient after heart transplantation due to end-stage ischemic cardiomyopathy with significant clinical and echocardiographic improvement 3 months after the introduction of sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor. This new class of drugs is proved to be beneficial in heart failure patients, especially with reduced ejection fraction (HFrEF), but they have not yet been used in heart failure patients after heart transplantation. We believe that the increase of left ventricular systolic function, improvement of global longitudinal strain, and reduction of pulmonary hypertension with consequent clinical recovery in our patient may have been caused by sacubitril/valsartan.

引用

页码：413 / 415

页数：3

共 6 条

[1] Adult heart transplant: indications and outcomes
Alraies, M. Chadi
Eckman, Peter
[J]. JOURNAL OF THORACIC DISEASE, 2014, 6 (08) : 1120 - 1128
[2] Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
McMurray, John J. V.
Packer, Milton
Desai, Akshay S.
Gong, Jim
Lefkowitz, Martin P.
Rizkala, Adel R.
Rouleau, Jean
Shi, Victor C.
Solomon, Scott D.
Swedberg, Karl
Zile, Michael R.
[J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (09) : 1062 - 1073
[3] International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010
Mehra, Mandeep R.
Crespo-Leiro, Maria G.
Dipchand, Anne
Ensminger, Stephan M.
Hiemann, Nicola E.
Kobashigawa, Jon A.
Madsen, Joren
Parameshwar, Jayan
Starling, Randall C.
Uber, Patricia A.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (07) : 717 - 727
[4] 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, Piotr
Voors, Adriaan A.
Anker, Stefan D.
Bueno, Hector
Cleland, John G. F.
Coats, Andrew J. S.
Falk, Volkmar
Ramon Gonzalez-Juanatey, Jose
Harjola, Veli-Pekka
Jankowska, Ewa A.
Jessup, Mariell
Linde, Cecilia
Nihoyannopoulos, Petros
Parissis, John T.
Pieske, Burkert
Riley, Jillian P.
Rosano, Giuseppe M. C.
Ruilope, Luis M.
Ruschitzka, Frank
Rutten, Frans H.
van der Meer, Peter
[J]. EUROPEAN HEART JOURNAL, 2016, 37 (27) : 2129 - U130
[5] Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection
Stewart, S
Winters, GL
Fishbein, MC
Tazelaar, HD
Kobashigawa, J
Abrams, J
Andersen, CB
Angelini, A
Berry, GJ
Burke, MM
Demetris, AJ
Hammond, E
Itescu, S
Marboe, CC
McManus, B
Reed, EF
Reinsmoen, NL
Rodriguez, ER
Rose, AG
Rose, M
Suciu-Focia, N
Zeevi, A
Billingham, ME
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11) : 1710 - 1720
[6] Angiotensin Receptor Neprilysin Inhibitor LCZ696 Attenuates Cardiac Remodeling and Dysfunction After Myocardial Infarction by Reducing Cardiac Fibrosis and Hypertrophy
von Lueder, Thomas G.
Wang, Bing H.
Kompa, Andrew R.
Huang, Li
Webb, Randy
Jordaan, Pierre
Atar, Dan
Krum, Henry
[J]. CIRCULATION-HEART FAILURE, 2015, 8 (01) : 71 - U130

← 1 →